We provide you with 20 years of free, institutional-grade data for BNOX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BNOX. Explore the full financial landscape of BNOX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Bionomics(NASDAQ:BNOX) 
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the ...
Website: https://www.bionomics.com.au
Founded: 1996
IPO Price: $12.35 (Dec 16, 2021)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about BNOX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.